David A. Schwartz

Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections

David A. Schwartz, Ashley Graham · Viruses · 2020 · 956 citations · Full text

Veterinary Medicine, Infectious Diseases, Maternal Health +15

Predictors of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality

Mitchell J. Schwaber, Shiri Klarfeld-Lidji, Shiri Navon‐Venezia et al. · Antimicrobial Agents and Chemotherapy · 2007 · 487 citations

Life Sciences, Infectious Diseases, Antimicrobial Resistance +16

Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing <i>Enterobacteriaceae</i>

Mitchell J. Schwaber, Shiri Navon‐Venezia, Keith S. Kaye et al. · Antimicrobial Agents and Chemotherapy · 2006 · 415 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

Matthew J. Abrams, Malik E. Juweid, C I tenKate et al. · PubMed · 1990 · 361 citations

Medicine, Nuclear Medicine, Pharmacokinetics +15

Adalimumab for the treatment of fistulas in patients with Crohn’s disease

J F Colombel, David A. Schwartz, William J. Sandborn et al. · Gut · 2009 · 358 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17